You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Correction: Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population
- 2. USP39: a key regulator in malignant tumor progression
- 3. Johnson & Johnson submits application to the European Medicines Agency seeking indication extension of AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer and HRR gene alterations
- 4. Inflammatory-based prognostic indicators in prostate cancer: evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications
- 5. Aspirin a day keeps bowel cancer at bay
- 6. FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling
- 7. Turning ultrasound into medicine: Low-intensity ultrasound unlocks precision cancer treatment
- 8. A review of circular RNAs in colorectal cancer: insights into biomarker discovery and therapeutic targeting
- 9. Association between genomic features and toxic metal(loid) accumulation in left-sided and right-sided colorectal cancer
- 10. Bioinformatics and experimental unveiling of TIMP1 as a novel therapeutic target in colorectal cancer ferroptosis
Last updated at 5:51 GMT
Hot News Makers
Health/Pharma Companies
-
55612.92
-
22854.59
-
15608.23
-
7531.13
-
4621.55
-
4594.45
-
4570.91
-
4077.20
-
3232.67
-
2630.28
Drugs, Treatments, Trials
-
4863.37
-
3919.77
-
2830.76
-
2594.82
-
2376.54
-
1627.50
-
1509.88
-
1364.11
-
999.76
-
949.77
Last updated at 5:10 GMT
